{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T23:02:26Z","timestamp":1767049346378,"version":"3.48.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-025-13747-w","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T22:58:22Z","timestamp":1767049102000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prices, availability, and affordability of selected medicines for asthma management in Nigeria: a nationwide study"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0131-440X","authenticated-orcid":false,"given":"Kosisochi Chinwendu","family":"Amorha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faith Nnenna","family":"Eze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ifeoma Felicita","family":"Uzuh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somtochi Prosper","family":"Nwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer Chigozie","family":"Iganga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chidera Edith","family":"Eze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chukwudi Richard","family":"Ifeanyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adaora Anthonia","family":"Agubata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chisom Sandra","family":"Ibenekwu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Immaculata Chidimma","family":"Aniebonam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela Chinasa","family":"Ani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chinelo Cynthia","family":"Ezenwafor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emelda Chinemerem","family":"Omene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oluoma Maryjane","family":"Chukwuwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chisom Peace","family":"Ezeala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chidimma Elizabeth","family":"Mbakamma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chinagozim Rufina","family":"Nworah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mmaduabuchi Desmond","family":"Udoji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kossy Maryann","family":"Ochie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth Nkechi","family":"Sabastine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ogechi Christiana","family":"Obi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita Nnenne","family":"Oparaocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chibueze Raymond","family":"Okoye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oluebubechukwu Praise","family":"Eze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"issue":"3","key":"13747_CR1","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1177\/1460458217723169","volume":"25","author":"D Spathis","year":"2019","unstructured":"Spathis D, Vlamos P. Diagnosing asthma and chronic obstructive pulmonary disease with machine learning. Health Inf J. 2019;25(3):811\u201327. https:\/\/doi.org\/10.1177\/1460458217723169.","journal-title":"Health Inf J"},{"issue":"1","key":"13747_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.25259\/JPATS_19_2020","volume":"2","author":"B Sanyang","year":"2021","unstructured":"Sanyang B, Jagne E, Sefa N, Touray S. Availability, cost, and affordability of asthma and chronic obstructive pulmonary disease medications in The Gambia. JPATS. 2021;2(1):33\u201341. https:\/\/doi.org\/10.25259\/JPATS_19_2020.","journal-title":"JPATS"},{"issue":"9","key":"13747_CR3","doi-asserted-by":"publisher","first-page":"0222281","DOI":"10.1371\/journal.pone.0222281","volume":"14","author":"OB Ozoh","year":"2019","unstructured":"Ozoh OB, Aderibigbe SA, Ayuk AC, Desalu OO, Oridota OE, Olufemi O, et al. The prevalence of asthma and allergic rhinitis in Nigeria: a nationwide survey among children, adolescents and adults. PLoS one. 2019;14(9):0222281. https:\/\/doi.org\/10.1371\/journal.pone.0222281.","journal-title":"PLoS One"},{"key":"13747_CR4","doi-asserted-by":"publisher","first-page":"883784","DOI":"10.3389\/fpubh.2022.883784","volume":"10","author":"Z Kharaba","year":"2022","unstructured":"Kharaba Z, Feghali E, El Husseini F, Sacre H, Abou Selwan C, Saadeh S, et al. An assessment of quality of life in patients with asthma through physical, emotional, social, and occupational aspects. A cross-sectional study. Front Public Health. 2022;10:883784. https:\/\/doi.org\/10.3389\/fpubh.2022.883784.","journal-title":"Front Public Health"},{"issue":"2","key":"13747_CR5","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1183\/20734735.0019-2019","volume":"15","author":"I Stoodley","year":"2019","unstructured":"Stoodley I, Williams L, Thompson C, Scott H, Wood L. Evidence for lifestyle interventions in asthma. Breathe (Sheff). 2019;15(2):e50\u201361. https:\/\/doi.org\/10.1183\/20734735.0019-2019.","journal-title":"Breathe (sheff)"},{"key":"13747_CR6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.prry.2021.07.004","volume":"41","author":"MD Ughasoro","year":"2022","unstructured":"Ughasoro MD, Eze JN, Oguonu T, Onwujekwe EO. Burden of childhood and adolescence asthma in Nigeria: disability adjusted life years. Paediatr Respir Rev. 2022;41:61\u201367. https:\/\/doi.org\/10.1016\/j.prry.2021.07.004.","journal-title":"Paediatr Respir Rev"},{"issue":"1","key":"13747_CR7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41533-022-00281-z","volume":"32","author":"A Tabyshova","year":"2022","unstructured":"Tabyshova A, Sooronbaev T, Akylbekov A, Mademilov M, Isakova A, Erkinbaeva A, et al. Medication availability and economic barriers to adherence in asthma and COPD patients in low-resource settings. NPJ Prim Care Respir Med. 2022;32(1):20. https:\/\/doi.org\/10.1038\/s41533-022-00281-z.","journal-title":"NPJ Prim Care Respir Med"},{"key":"13747_CR8","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s40273-013-0095-9","volume":"31","author":"ZUD Babar","year":"2013","unstructured":"Babar ZUD, Lessing C, Mace C, Bissell K. The availability, pricing and affordability of three essential asthma medicines in 52 low- and middle-income countries. Pharmacoeconomics. 2013;31:1063\u201382.","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"13747_CR9","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3390\/ijerph16040605","volume":"16","author":"K Bissell","year":"2019","unstructured":"Bissell K, Ellwood P, Ellwood E, Chiang C, Marks GB, El Sony A, et al. Essential medicines at the national level. The global asthma network\u2019s essential asthma medicines survey 2014. Int J Environ Res Public Health. 2019;16(4):605. https:\/\/doi.org\/10.3390\/ijerph16040605.","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"13747_CR10","doi-asserted-by":"publisher","first-page":"324","DOI":"10.4103\/2141-9248.117927","volume":"3","author":"CC Onyedum","year":"2013","unstructured":"Onyedum CC, Ukwaja KN, Desalu OO, Ezeudo C. Challenges in the management of bronchial asthma among adults in Nigeria: a systematic review. Ann Med Health Sci Res. 2013;3(3):324\u201329. https:\/\/doi.org\/10.4103\/2141-9248.117927.","journal-title":"Ann Med Health Sci Res"},{"issue":"9","key":"13747_CR11","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1080\/17476348.2019.1651201","volume":"13","author":"OB Ozoh","year":"2019","unstructured":"Ozoh OB, Ayuk AC, Ukwaja KN, Desalu OO, Olufemi O, Aderibigbe SA, et al. Asthma management and control in Nigeria: the asthma insight and reality Nigeria (AIRNIG) study. Expert Rev Respir Med. 2019;13(9):917\u201327. https:\/\/doi.org\/10.1080\/17476348.2019.1651201.","journal-title":"Expert Rev Respir Med"},{"issue":"10","key":"13747_CR12","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.4103\/njcp.njcp_133_17","volume":"20","author":"Udeh El","year":"2017","unstructured":"Udeh El, Iheanacho P, Chukwu JN. Health care financing in Nigeria: implications for achieving universal health coverage. Niger J Clin Pract. 2017;20(10):1255\u201365. https:\/\/doi.org\/10.4103\/njcp.njcp_133_17.","journal-title":"Niger J Clin Pract"},{"issue":"10","key":"13747_CR13","doi-asserted-by":"publisher","first-page":"e1423","DOI":"10.1016\/S2214-109X(22)00330-8","volume":"10","author":"M Stolbrink","year":"2022","unstructured":"Stolbrink M, Thomson H, Hadfield RM, Ozoh OB, Nantanda R, Jayasooriya S, et al. The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review. Lancet Glob Health. 2022;10(10):e1423\u201342. https:\/\/doi.org\/10.1016\/S2214-109X(22)00330-8.","journal-title":"Lancet Glob Health"},{"key":"13747_CR14","doi-asserted-by":"publisher","first-page":"6640133","DOI":"10.1155\/2021\/6640133","volume":"2021","author":"EM Oridanigo","year":"2021","unstructured":"Oridanigo EM, Salgedo WB, Kebene FG. Affordability of essential medicines and associated factors in public health facilities of Jimma Zone, Southwest Ethiopia. Adv Pharmacol Pharm Sci. 2021;2021:6640133. https:\/\/doi.org\/10.1155\/2021\/6640133.","journal-title":"Adv Pharmacol Pharm Sci"},{"issue":"3","key":"13747_CR15","doi-asserted-by":"publisher","first-page":"e0000072","DOI":"10.1371\/journal.pgph.0000072","volume":"2","author":"A Lotfizadeh","year":"2022","unstructured":"Lotfizadeh A, Palafox B, Takallou A, Balabanova D, McKee M, Murphy A. Factors associated with the availability and affordability of essential cardiovascular disease medicines in low- and middle-income countries: a systematic review. PLoS Glob Public Health. 2022;2(3):e0000072. https:\/\/doi.org\/10.1371\/journal.pgph.0000072.","journal-title":"PLoS Glob Public Health"},{"issue":"9659","key":"13747_CR16","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0140-6736(08)61762-6","volume":"373","author":"A Cameron","year":"2009","unstructured":"Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet. 2009;373(9659):240\u201349. https:\/\/doi.org\/10.1016\/S0140-6736(08)61762-6.","journal-title":"Lancet"},{"key":"13747_CR17","doi-asserted-by":"publisher","unstructured":"Wirtz VJ, Kaplan WA, Kwan GF, Laing RO. Access to medications for cardiovascular diseases in low- and middle-income countries. Circulation. 2016;133(21):2076\u201385. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.008722.","DOI":"10.1161\/CIRCULATIONAHA.115.008722"},{"key":"13747_CR18","unstructured":"Central Bank of Nigeria (CBN). Exchange rates. Available from: https:\/\/www.cbn.gov.ng. Accessed 29 Jan 2024."},{"key":"13747_CR19","unstructured":"World Health Organization (WHO). Measuring medicine prices, availability, affordability and price components, 2nd Edition. www.who.int. 2012. https:\/\/www.who.int. Accessed June 17, 2012."},{"key":"13747_CR20","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1186\/s12913-019-4221-z","volume":"19","author":"L Kasonde","year":"2019","unstructured":"Kasonde L, Tordrup D, Naheed A, Zeng W, Ahmed S, Babar ZUD. Evaluating medicine prices, availability and affordability in Bangladesh using world health organisation and health action international methodology. BMC Health Serv Res. 2019;19:383. https:\/\/doi.org\/10.1186\/s12913-019-4221-z.","journal-title":"BMC Health Serv Res"},{"key":"13747_CR21","unstructured":"The Cable. Effects of exodus of pharmaceutical companies. The cable. 2024. https:\/\/www.thecable.ng\/effect-of-the-exodus-of-pharmaceutical-companies-on-nigeria\/. Accessed 9 Aug 2024."},{"issue":"8","key":"13747_CR22","doi-asserted-by":"publisher","first-page":"e252043","DOI":"10.1001\/jamahealthforum.2025.2043","volume":"6","author":"OJ Wouters","year":"2025","unstructured":"Wouters OJ, Denolle C, Wei J, Papanicolas I. Prices and affordability of essential medicines in 72 low-, middle-, and high-income markets. JAMA Health Forum. 2025;6(8):e252043. https:\/\/doi.org\/10.1001\/jamahealthforum.2025.2043.","journal-title":"JAMA Health Forum"},{"key":"13747_CR23","unstructured":"Salako P. Drug prices soar after pharma giants GSK and Sanofi exit Nigeria. Devex. 2024. https:\/\/www.devex.com\/news\/drug-prices-soar-after-pharma-giants-gsk-and-sanofi-exit-nigeria-107380. Accessed 9 Aug 2024."},{"key":"13747_CR24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40545-018-0156-8","volume":"11","author":"RM Conti","year":"2018","unstructured":"Conti RM, Nguyen KH, Rosenthal MB. Generic prescription drug price increases: which products will be affected by proposed anti-gouging legislation? J Pharm Policy Pract. 2018;11:29. https:\/\/doi.org\/10.1186\/s40545-018-0156-8.","journal-title":"J Pharm Policy Pract"},{"key":"13747_CR25","doi-asserted-by":"publisher","unstructured":"Darrow J, Kesselheim A. Promoting competition to address pharmaceutical prices. Health Aff. 2018. https:\/\/doi.org\/10.1377\/hpb20180116.967310.","DOI":"10.1377\/hpb20180116.967310"},{"key":"13747_CR26","unstructured":"IMS Institute for Healthcare Informatics. Price declines after branded medicines lose exclusivity in the U.S. 2016. https:\/\/www.iqvia.com\/-\/media\/iqvia\/pdfs\/institute-reports\/price-declines-after-branded-medicines-lose-exclusivity-in-the-us.pdf. Accessed 9 Aug 2024."},{"issue":"4","key":"13747_CR27","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1017\/cts.2020.18","volume":"4","author":"JM Kwan","year":"2020","unstructured":"Kwan JM, Toubat O, Harrison AM, Riddle M, Wu B, Kim H, et al. A nationwide assessment of perceptions of research-intense academic careers among predoctoral MD and MD-PhD trainees. J Clin Transl Sci. 2020;4(4):307\u201316. https:\/\/doi.org\/10.1017\/cts.2020.18.","journal-title":"J Clin Transl Sci"},{"issue":"3","key":"13747_CR28","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.healthpol.2010.10.006","volume":"99","author":"OO Desalu","year":"2011","unstructured":"Desalu OO, Onyedum CC, Iseh KR, Salawu FK, Salami AK. Asthma in Nigeria: are the facilities and resources available to support internationally endorsed standards of care? Health Policy. 2011;99(3):250\u201354. https:\/\/doi.org\/10.1016\/j.healthpol.2010.10.006.","journal-title":"Health Policy (new Y)"},{"issue":"12","key":"13747_CR29","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/j.healthpol.2016.09.018","volume":"120","author":"FS Alkhuzaee","year":"2016","unstructured":"Alkhuzaee FS, Almalki HM, Attar AY, Althubiani SI, Almuallim WA, Cheema E, et al. Evaluating community pharmacists\u2019 perspectives and practices concerning generic medicines substitution in Saudi Arabia: a cross-sectional study. Health Policy. 2016;120(12):1412\u201319. https:\/\/doi.org\/10.1016\/j.healthpol.2016.09.018.","journal-title":"Health Policy (new Y)"},{"issue":"2","key":"13747_CR30","doi-asserted-by":"publisher","first-page":"120","DOI":"10.5588\/ijtld.20.0762","volume":"25","author":"C Plum","year":"2021","unstructured":"Plum C, Stolbrink M, Zurba L, Bissell K, Ozoh BO, Mortimer K. Availability of diagnostic services and essential medicines for non-communicable respiratory diseases in African countries. Int J Tuberc Lung Dis. 2021;25(2):120\u201325. https:\/\/doi.org\/10.5588\/ijtld.20.0762.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"13747_CR31","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/tmi.13497","volume":"26","author":"OB Ozoh","year":"2020","unstructured":"Ozoh OB, Eze JN, Garba BI, Ojo OO, Okori E, Yiltok E, et al. Nationwide survey of the availability and affordability of asthma and COPD medicines in Nigeria. Trop Med Int Health. 2020;26(1):54\u201365. https:\/\/doi.org\/10.1111\/tmi.13497.","journal-title":"Trop Med Int Health"},{"key":"13747_CR32","doi-asserted-by":"publisher","unstructured":"Kibirige D, Kampiire L, Atuhe D, Nwebaze R, Katagira W, Muttamba W, et al. Access to affordable medicines and diagnostic tests for asthma and COPD in Sub Saharan Africa: the Ugandan perspective. BMC Pulm Med. 2017;17(1). https:\/\/doi.org\/10.1186\/s12890-017-0527-y.","DOI":"10.1186\/s12890-017-0527-y"},{"key":"13747_CR33","unstructured":"Federal Ministry of Health. Nigeria essential medicines list 7th edition. Health.gov.ng. 2020. https:\/\/site.health.gov.ng\/fdspd."},{"issue":"5","key":"13747_CR34","doi-asserted-by":"publisher","first-page":"692","DOI":"10.4103\/njcp.njcp_569_18","volume":"22","author":"OB Ozoh","year":"2019","unstructured":"Ozoh OB, Ndukwu CI, Desalu OO, Adeyeye OO, Adeniyi B. Knowledge and practice assessment, and self reported barriers to guideline based asthma management among doctors in Nigeria. Niger J Clin Pract. 2019;22(5):692\u2013700. https:\/\/doi.org\/10.4103\/njcp.njcp_569_18.","journal-title":"Niger J Clin Pract"},{"issue":"7","key":"13747_CR35","doi-asserted-by":"publisher","first-page":"473","DOI":"10.26719\/emhj.18.068","volume":"25","author":"E Heidari","year":"2019","unstructured":"Heidari E, Varmaghani M, Abdollahiasl A. Availability, pricing and affordability of selected medicines for noncommunicable diseases. East Mediterr Health J. 2019;25(7):473\u201380. https:\/\/doi.org\/10.26719\/emhj.18.068.","journal-title":"East Mediterr Health J"},{"issue":"2","key":"13747_CR36","doi-asserted-by":"publisher","first-page":"e0171284","DOI":"10.1371\/journal.pone.0171284","volume":"12","author":"M Ewen","year":"2017","unstructured":"Ewen M, Zweekhorst M, Regeer B, Laing R. Baseline assessment of WHO\u2019s target for both availability and affordability of essential medicines to treat non-communicable diseases. PLoS One. 2017;12(2):e0171284. https:\/\/doi.org\/10.1371\/journal.pone.0171284.","journal-title":"PLoS One"},{"issue":"2","key":"13747_CR37","first-page":"100","volume":"33","author":"OB Ozoh","year":"2014","unstructured":"Ozoh OB, Awokola BI, Buist SA. A survey of the knowledge of general practitioners, family physicians and pulmonologists in Nigeria regarding the diagnosis and treatment of chronic obstructive pulmonary disease. West Afr J Med. 2014;33(2):100\u201306. https:\/\/pubmed.ncbi.nlm.nih.gov\/25236825\/.","journal-title":"West Afr J Med"},{"issue":"1","key":"13747_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.25259\/JPATS_19_2020","volume":"2","author":"B Sanyang","year":"2021","unstructured":"Sanyang B, Jagne E, Sefa N, Touray S. Availability, cost, and affordability of asthma and chronic obstructive pulmonary disease medications in the Gambia. J Pan Afr Thorac Soc. 2021;2(1):33\u201341.","journal-title":"J Pan Afr Thorac Soc"},{"issue":"1","key":"13747_CR39","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1159\/000355473","volume":"23","author":"A Auta","year":"2013","unstructured":"Auta A, Bala ET, Shalkur D. Generic medicine substitution: a cross-sectional survey of the perception of pharmacists in North-Central, Nigeria. Med Princ Pract. 2013;23(1):53\u201358. https:\/\/doi.org\/10.1159\/000355473.","journal-title":"Med Princ Pract"},{"issue":"2","key":"13747_CR40","doi-asserted-by":"publisher","first-page":"78","DOI":"10.4103\/1817-1737.94524","volume":"7","author":"AE Fawibe","year":"2012","unstructured":"Fawibe AE, Onyedum CC, Sogaolu OM, Ajayi AO, Fasae AJ. Drug prescription pattern for asthma among Nigerian doctors in general practice: a cross-sectional survey. Ann Thorac Med. 2012;7(2):78. https:\/\/doi.org\/10.4103\/1817-1737.94524.","journal-title":"Ann Thorac Med"},{"issue":"2","key":"13747_CR41","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1002\/puh2.9","volume":"1","author":"YA Adebisi","year":"2022","unstructured":"Adebisi YA, Nwogu IB, Alaran AJ, Badmos AO, Bamgboye AO, Rufai BO, et al. Revisiting the issue of access to medicines in Africa: challenges and recommendations. Public Health Challenges. 2022;1(2):e9. https:\/\/doi.org\/10.1002\/puh2.9.","journal-title":"Public Health Challenges"},{"issue":"1","key":"13747_CR42","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1016\/S2214-109X(24)00442-X","volume":"13","author":"L Oldfield","year":"2025","unstructured":"Oldfield L, Penm J, Mirzaei A, Moles R. Prices, availability, and affordability of adult medicines in 54 low-income and middle-income countries: evidence based on secondary analysis. Lancet Glob Health. 2025;13(1):e50\u201358. https:\/\/doi.org\/10.1016\/S2214-109X(24)00442-X.","journal-title":"Lancet Glob Health"},{"key":"13747_CR43","doi-asserted-by":"publisher","first-page":"1604375","DOI":"10.3389\/ijph.2022.1604375","volume":"67","author":"M Bibi","year":"2022","unstructured":"Bibi M, Haq NU, Kareem A, Ullah H, Baloch N, Rehman G, Nasim A. Evaluation of availability, prices, and affordability of selected essential medicines in Balochistan, Pakistan. Int J Public Health. 2022;67:1604375. https:\/\/doi.org\/10.3389\/ijph.2022.1604375.","journal-title":"Int J Public Health"},{"issue":"5","key":"13747_CR44","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.jval.2012.04.004","volume":"15","author":"A Cameron","year":"2012","unstructured":"Cameron A, Mantel-Teeuwisse AK, Leufkens HGM, Laing RO. Switching from originator brand medicines to generic equivalents in selected developing countries: how much could be saved? Value Health. 2012;15(5):664\u201373. https:\/\/doi.org\/10.1016\/j.jval.2012.04.004.","journal-title":"Value in Health"},{"issue":"5","key":"13747_CR45","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.jaip.2023.12.049","volume":"12","author":"JFM van Boven","year":"2024","unstructured":"van Boven JFM, Lavorini F, Agh T, Sadatsafavi M, Patino O, Muresan B. Cost-effectiveness and impact on healthcare utilization of interventions to improve medication adherence and outcomes in asthma and COPD: a systematic literature review. J Allergy Clin Immunol Pract. 2024;12(5):1228\u201343. https:\/\/doi.org\/10.1016\/j.jaip.2023.12.049.","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-13747-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-025-13747-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-13747-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T22:58:24Z","timestamp":1767049104000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12913-025-13747-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13747"],"URL":"https:\/\/doi.org\/10.1186\/s12913-025-13747-w","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"11 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical clearance was approved by the Health and Research Ethics Committee, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu State, Nigeria, on 26 January 2024 (UNTH\/HREC\/2024\/01\/546).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1617"}}